Description

AMLODAC 5 MG (1X30)

Indications

AMLODAC 5 MG is primarily indicated for the management of hypertension (high blood pressure) and for the treatment of angina pectoris (chest pain). It is used to lower blood pressure in patients with essential hypertension, thereby reducing the risk of cardiovascular events such as stroke and heart attack. Additionally, AMLODAC can be beneficial in patients with chronic stable angina, improving exercise tolerance and decreasing the frequency of angina attacks.

Mechanism of Action

AMLODAC contains amlodipine, which is a dihydropyridine calcium channel blocker. It works by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle. This action leads to vasodilation (widening of blood vessels), which decreases peripheral vascular resistance and lowers blood pressure. By reducing the workload on the heart and improving blood flow, amlodipine alleviates symptoms of angina and enhances exercise capacity in patients with coronary artery disease.

Pharmacological Properties

Amlodipine is characterized by its long half-life, which allows for once-daily dosing. It is well-absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 6 to 12 hours after oral administration. The drug is extensively metabolized in the liver, primarily via the cytochrome P450 system, and is excreted mainly in the urine as metabolites. Amlodipine’s pharmacokinetics are not significantly affected by food intake, making it convenient for patients to administer at any time of day.

Contraindications

AMLODAC is contraindicated in patients with known hypersensitivity to amlodipine or any of the components of the formulation. It should not be used in patients with severe hypotension, shock (including cardiogenic shock), or aortic stenosis. Additionally, caution is advised in patients with severe liver impairment, as this may affect the metabolism and clearance of the drug.

Side Effects

Common side effects associated with AMLODAC include peripheral edema, dizziness, fatigue, and palpitations. Other less common side effects may include headache, flushing, nausea, and abdominal pain. In rare instances, serious adverse effects such as hypotension, tachycardia, or allergic reactions may occur. Patients should be advised to report any unusual symptoms to their healthcare provider promptly.

Dosage and Administration

The recommended starting dose of AMLODAC is 5 mg once daily. Depending on the patient’s response and tolerability, the dose may be increased to a maximum of 10 mg once daily. It is important to take AMLODAC consistently at the same time each day to maintain stable blood levels. The tablets should be swallowed whole with water and can be taken with or without food.

Interactions

Amlodipine may interact with several medications, which can alter its effectiveness or increase the risk of side effects. Co-administration with other antihypertensive agents may lead to additive effects, resulting in excessive hypotension. Caution should be exercised when using amlodipine with medications that affect hepatic enzymes, such as certain antifungals and antibiotics, as they may alter amlodipine metabolism. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements.

Precautions

Patients with heart failure or significant aortic stenosis should use AMLODAC with caution, as it may exacerbate these conditions. Regular monitoring of blood pressure is essential, especially during the initiation of therapy or when adjusting the dose. In elderly patients or those with renal impairment, a lower starting dose may be considered to minimize the risk of adverse effects. Pregnant or breastfeeding women should consult their healthcare provider before using AMLODAC, as the safety of amlodipine during pregnancy and lactation has not been fully established.

Clinical Studies

Numerous clinical studies have demonstrated the efficacy of amlodipine in the management of hypertension and angina. A randomized controlled trial published in the Journal of Hypertension showed that amlodipine significantly reduced systolic and diastolic blood pressure compared to placebo, with a favorable safety profile. Another study in the American Journal of Cardiology reported that patients treated with amlodipine experienced a marked improvement in exercise tolerance and a reduction in angina frequency. These studies support the use of AMLODAC as a first-line treatment option for patients with hypertension and stable angina.

Conclusion

AMLODAC 5 MG is an effective medication for the management of hypertension and angina pectoris. Its mechanism of action as a calcium channel blocker provides significant cardiovascular benefits, including reduced blood pressure and improved exercise capacity. While generally well-tolerated, it is important for patients to be aware of potential side effects and drug interactions. Regular follow-up with healthcare providers is essential to ensure optimal treatment outcomes and to monitor for any adverse effects.